OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 5.98
+0.20 (3.46%)
Feb 11, 2026, 9:14 AM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 73.1 million as of February 10, 2026. Its market cap has increased by 3.84% in one year.
Market Cap
73.10M
Enterprise Value
69.01M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.98
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 73.10M, a decrease of -17.88%. That is a compound annual growth rate of -3.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 75.00M | -12.28% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | 89.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexin Pharmaceuticals AB | 112.24M |
| Biosergen AB | 106.61M |
| Active Biotech AB | 101.22M |
| Alligator Bioscience AB | 96.21M |
| Spago Nanomedical AB | 83.03M |
| Scandinavian ChemoTech AB | 82.87M |
| Alzinova AB | 73.97M |
| ExpreS2ion Biotech Holding AB | 54.65M |